This article was originally posted on March 31, 2014.
The complexities of diabetes can’t be fully understood in a lab or in a clinic alone. Sometimes, information coming from the lab informs clinical researchers about what they should study in people with diabetes. Other times, trends noticed in patient visits can lead to an important study at the bench.
The back-and-forth, cross-disciplinary nature of diabetes research and medical research in general is known as translational research.
“It is a reciprocal journey from initial observation in lab or clinic to understanding the relevance of the finding to patients, practice and population health,” said Allison Goldfine, M.D., Head of the Section on Clinical, Behavioral and Outcomes Research.
Joslin Diabetes Center is dedicated to translational research; so much so that Joslin will soon open the doors to the newly constructed Translational Research Center for the Cure of Diabetes. This center will improve communication and encourage collaboration between basic science researchers and clinical researchers.
But Joslin hasn’t been waiting for the Translational Center’s unveiling to do this type of important work. Translational research has been part of Joslin’s approach to understanding more about diabetes for years. Continue reading –>